Resultados de búsqueda - Boland, M.R.
- Mostrando 1 - 8 Resultados de 8
-
1
-
2
-
3
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis por Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Publicado 2021Texto -
4
-
5
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis por Boland, M. R., Lowery, A. J., Walsh, S., Beddy, D., Prichard, R. S., O'Shea, D., Skehan, S. J., McDermott, E. W.
Publicado 2014Texto -
6
-
7
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy por Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S.
Publicado 2017Texto -
8
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer por Davey, M G, Ryan, É J, Folan, P J, O’Halloran, N, Boland, M R, Barry, M K, Sweeney, K J, Malone, C M, McLaughlin, R J, Kerin, M J, Lowery, A J
Publicado 2021Texto